{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:30:55Z","timestamp":1792614655346,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H05697"],"award-info":[{"award-number":["20H05697"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["JP20gm1210006"],"award-info":[{"award-number":["JP20gm1210006"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005926","name":"Cosmetology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012331","name":"LEO Fondet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jid.2025.04.024","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:45:30Z","timestamp":1750808730000},"page":"2410-2416.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lessons from TNF-\u03b1 Inhibitor\u2013Induced Alopecia Areata: Does TNF-\u03b1 Operate as a Hair Follicle Immune Privilege Guardian under Inflammatory Conditions?"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7272-206X","authenticated-orcid":false,"given":"Sofia M.","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Gilliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Gilhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-9358","authenticated-orcid":false,"given":"Ralf","family":"Paus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.04.024_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/jdv.12932","article-title":"Plasmacytoid dendritic cells in alopecia areata: missing link?","volume":"30","author":"Abou Rahal","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.04.024_bib96","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/bjd.18479","article-title":"An osteopontin-derived peptide inhibitshuman hair growth at least in part by decreasing fibroblast growth factor-7 production in outer root sheath keratinocytes","volume":"182","author":"Alam","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1395945","article-title":"Depletion of donor dendritic cells ameliorates immunogenicity of both skin and hind limb transplants","volume":"15","author":"Ashraf","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jid.2017.11.012","article-title":"Increased risk of vitiligo following anti-tumor necrosis factor therapy: a 10-year population-based cohort study","volume":"138","author":"Bae","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/bjd.21716","article-title":"Paradoxical reactions and biologic agents: a French cohort study of 9303 patients","volume":"187","author":"Bataille","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib5","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1038\/s41598-018-23571-4","article-title":"Microbiota composition may predict anti-Tnf alpha response in spondyloarthritis patients: an exploratory study","volume":"8","author":"Bazin","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2025.04.024_bib6","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.3390\/ijms22084190","article-title":"Type I interferon production of plasmacytoid dendritic cells under control","volume":"22","author":"Bencze","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2025.04.024_bib7","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/rheumatology\/keu145","article-title":"Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database","volume":"53","author":"B\u00e9n\u00e9","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2025.04.024_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094260","article-title":"Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata","volume":"9","author":"Bertolini","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2025.04.024_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/jamadermatol.2023.4445","article-title":"The best psoriasis medications emerge","volume":"160","author":"Blauvelt","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000162180","article-title":"Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab)","volume":"217","author":"Chaves","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2025.04.024_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar3150","article-title":"Type I IFN and TNF\u03b1 cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance","volume":"12","author":"Cantaert","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2025.04.024_bib14","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001065","article-title":"Transcriptome and function of novel immunosuppressive autoreactive invariant natural killer T cells that are absent in progressive multiple sclerosis","volume":"8","author":"Carri\u00f3n","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jid.2025.04.024_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103575","article-title":"Small-molecule modulators of tumor necrosis factor signaling","volume":"28","author":"Ch\u00e9dotal","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jid.2025.04.024_bib16","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.febslet.2011.04.025","article-title":"Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity","volume":"585","author":"Chen","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jid.2025.04.024_bib17","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M15-0729","article-title":"Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study","volume":"164","author":"Cleynen","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jid.2025.04.024_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adh0152","article-title":"Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche","volume":"9","author":"Cohen","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2016-eular.2114","article-title":"AB0034 pharmacokinetics and safety of BCD-057, adalimumab biosimilar candidate, compared to Humira in healthy volunteers (results of Phase I clinical study)","volume":"75","author":"Eremeeva","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2025.04.024_bib22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-a","article-title":"Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles","volume":"140","author":"Ettefagh","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1468-3083.2010.03770.x","article-title":"Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-\u03b1 blocker agents: report of five cases and review of the literature","volume":"25","author":"Ferran","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.04.024_bib24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1159\/000485288","article-title":"TNF-\u03b1 regulates mast cell functions by inhibiting cell degranulation","volume":"44","author":"Gao","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jid.2025.04.024_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaut.2018.04.001","article-title":"iNKT cells ameliorate human autoimmunity: lessons from alopecia areata","volume":"91","author":"Ghraieb","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jid.2025.04.024_bib26","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.04.024_bib97","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jisp.2020.05.001","article-title":"Mouse Models of Alopecia Areata: C3H\/HeJ Mice Versus the Humanized AA Mouse Model","volume":"20","author":"Gilhar","year":"2020","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jid.2025.04.024_bib27","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jaci.2019.08.035","article-title":"Frontiers in alopecia areata pathobiology research","volume":"144","author":"Gilhar","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.autrev.2016.03.008","article-title":"Alopecia areata: animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies","volume":"15","author":"Gilhar","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2025.04.024_bib29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ced\/llac104","article-title":"Alopecia areata and risk of atopic autoimmune conditions: population-based cohort study","volume":"48","author":"Holmes","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib94","first-page":"623","article-title":"Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model","volume":"164","author":"Ito","year":"2004","journal-title":"Am J Pahtol"},{"key":"10.1016\/j.jid.2025.04.024_bib95","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2133.2005.06453.x","article-title":"Interferom-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles","volume":"152","author":"Ito","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5109772","article-title":"Interleukin-15 and tumor necrosis factor-\u03b1 in Iraqi patients with alopecia areata","volume":"2023","author":"Kamil","year":"2023","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.jid.2025.04.024_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000174826","article-title":"Biologic agents and alopecia areata","volume":"218","author":"Katoulis","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2025.04.024_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2310\/7750.2008.07095","article-title":"Alopecia areata following adalimumab","volume":"13","author":"Kirshen","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2025.04.024_bib33","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4049\/jimmunol.1000560","article-title":"Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells","volume":"185","author":"Kleijwegt","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1359-6101(02)00019-9","article-title":"Role of TNF\/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments","volume":"13","author":"Kollias","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jid.2025.04.024_bib35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/exd.12836","article-title":"Human hair follicle organ culture: theory, application and perspectives","volume":"24","author":"Langan","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80768","article-title":"Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata","volume":"12","author":"Laufer Britva","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jid.2025.04.024_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/abd1806-4841.20142944","article-title":"Alopecia universalis during treatment with leflunomide and adalimumab - case report","volume":"89","author":"Lazzarini","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib39","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jid.2023.11.006","article-title":"Spatial distribution and functional impact of human scalp hair follicle microbiota","volume":"144","author":"Lousada","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib40","article-title":"Oxidative stress and alopecia areata","volume":"10","author":"Ma","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2025.04.024_bib41","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jid.2024.05.015","article-title":"Paradoxical psoriasis: an updated review of clinical features, pathogenesis, and treatment options","volume":"144","author":"Maronese","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib42","first-page":"947","article-title":"Novel insights into the management of rheumatoid arthritis: one year in review 2024","volume":"42","author":"Molteni","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2025.04.024_bib90","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1365-2230.2008.03127.x","article-title":"Psoriasiform eruption with alopecia areata during infliximab therapy","volume":"34","author":"Nakagomi","year":"2009","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1016\/j.jid.2025.04.024_bib93","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/exd.13238","article-title":"T cell \u201cinduced-self\u201d MHC class I\/peptide complexes may enable \u201cde novo\u201d tolerance induction to neo-antigens occuring outside of the thymus: Lessons from the hair follicle","volume":"26","author":"Oelert","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ijd.15658","article-title":"IFN-\u03b1 and TNF-\u03b1 serum levels and their association with disease severity in Egyptian children and adults with alopecia areata","volume":"60","author":"Omar","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/0378-6323.113097","article-title":"Alopecia areata in a patient receiving infliximab","volume":"79","author":"Ormaechea-P\u00e9rez","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2025.04.024_bib88","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00393-018-0464-z","article-title":"Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab","volume":"77","author":"Ostojic","year":"2018","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.jid.2025.04.024_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/09273940802596559","article-title":"Alopecia areata during etanercept therapy","volume":"17","author":"Pan","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jid.2025.04.024_bib46","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.4049\/jimmunol.158.8.3673","article-title":"Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha","volume":"158","author":"Parry","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2004.09.014","article-title":"A 'hairy' privilege","volume":"26","author":"Paus","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib48","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000113945","article-title":"Alopecia areata universalis elicited during treatment with adalimumab","volume":"216","author":"Pelivani","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2025.04.024_bib92","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1365-2133.1996.d01-1099.x","article-title":"Effects of interleukins, coly-stimulating factor and tumor necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumor necrosis factor alpha in alopecia areata","volume":"146","author":"Philpott","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib49","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood-2016-04-711275","article-title":"TNF-\u03b1 priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment","volume":"128","author":"Pierini","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jid.2025.04.024_bib50","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4049\/jimmunol.1901358","article-title":"TNF-\u03b1 regulates human plasmacytoid dendritic cells by suppressing IFN-\u03b1 production and enhancing T cell activation","volume":"206","author":"Psarras","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1523-1747.1998.00228.x","article-title":"MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo","volume":"111","author":"R\u00fcckert","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib52","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1046\/j.1365-2133.2000.03784.x","article-title":"High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo","volume":"143","author":"R\u00fcckert","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40259-015-0150-5","article-title":"A randomized, Phase I pharmacokinetic study comparing SB2 and infliximab reference product (Remicade(\u00ae)) in healthy subjects","volume":"29","author":"Shin","year":"2015","journal-title":"BioDrugs"},{"key":"10.1016\/j.jid.2025.04.024_bib54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","article-title":"Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer","volume":"57","author":"Shouse","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2025.04.024_bib55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/bjd\/ljae088","article-title":"Review of global epidemiology data for alopecia areata highlights gaps and a call for action","volume":"191","author":"Sibbald","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib56","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/bjd.16126","article-title":"Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics","volume":"178","author":"Stoffel","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib57","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2005.03.039","article-title":"Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study","volume":"52","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103217","article-title":"Interleukin-15 is a hair follicle immune privilege guardian","volume":"145","author":"Suzuki","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jid.2025.04.024_bib91","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1101\/gad.1387406","article-title":"Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion","volume":"20","author":"Tong","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2025.04.024_bib59","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archderm.142.12.1653","article-title":"Alopecia areata during treatment with biologic agents","volume":"142","author":"Tosti","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102711","article-title":"Resident human dermal \u03b3\u03b4T-cells operate as stress-sentinels: lessons from the hair follicle","volume":"124","author":"Uchida","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jid.2025.04.024_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cgh.2023.06.025","article-title":"Tumor necrosis factor inhibitors in inflammatory bowel disease and risk of immune mediated inflammatory diseases","volume":"22","author":"Ward","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jid.2025.04.024_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/biom14010020","article-title":"Controlling hair loss by regulating apoptosis in hair follicles: a comprehensive overview","volume":"14","author":"Wang","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jid.2025.04.024_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14728214.2024.2303116","article-title":"Novel and emerging drugs for the treatment of Crohn's disease: a review of phase II and III trials","volume":"29","author":"Wetwittayakhlang","year":"2024","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jid.2025.04.024_bib65","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamaneurol.2024.3524","article-title":"Risk of inflammatory central nervous system diseases after tumor necrosis factor-inhibitor treatment for autoimmune diseases: a systematic review and meta-analysis","volume":"81","author":"Xie","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jid.2025.04.024_bib66","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2025.04.024_bib67","article-title":"Novel potential therapeutic targets of alopecia areata","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaa2155","article-title":"Analysis of single-cell cytokine secretion reveals a role for paracrine signaling in coordinating macrophage responses to TLR4 stimulation","volume":"8","author":"Xue","year":"2015","journal-title":"Sci Signal"},{"key":"10.1016\/j.jid.2025.04.024_bib69","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","article-title":"Role of TNF-TNF Receptor 2 signal in regulatory T cells and its therapeutic implications","volume":"9","author":"Yang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.04.024_bib70","first-page":"596","article-title":"Alopecia universalis and onychodystrophy during treatment with adalimumab","volume":"33","author":"Youssef","year":"2020","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.jid.2025.04.024_bib71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nm.4019","article-title":"Suppressive activity of human regulatory T cells is maintained in the presence of TNF","volume":"22","author":"Zaragoza","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2025.04.024_bib72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/JLB.1A0821-466R","article-title":"Effects of TNF-\u03b1 deletion on iNKT cell development, activation, and maturation in the steady-state and chronic alcohol-consuming mice","volume":"112","author":"Zhang","year":"2022","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jid.2025.04.024_bib89","first-page":"450","article-title":"Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible","volume":"11","author":"Zschoche","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2025.04.024_bibe1","first-page":"49","article-title":"Concomitant alopecia areata and hypertrichosis after infliximab therapy: rara avis","volume":"38","author":"Akarsu","year":"2013","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.jid.2025.04.024_bibe2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D331C9H7FX","article-title":"Alopecia areata universalis during off-label treatment with Infliximab in a patient with Beh\u00e7et disease","volume":"16","author":"Beccastrini","year":"2010","journal-title":"Dermatol Online J."},{"key":"10.1016\/j.jid.2025.04.024_bibe3","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/rheumatology\/keu145","article-title":"Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database","volume":"53","author":"B\u00e9n\u00e9","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2025.04.024_bibe4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000162180","article-title":"Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab)","volume":"217","author":"Chaves","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2025.04.024_bibe5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M15-0729","article-title":"Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study","volume":"164","author":"Cleynen","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jid.2025.04.024_bibe6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/DAD.0b013e3181ef7403","article-title":"Psoriatic alopecia\/alopecia areata-like reactions secondary to anti-tumor necrosis factor-\u03b1 therapy: a novel cause of noncicatricial alopecia","volume":"33","author":"Doyle","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jid.2025.04.024_bibe7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-a","article-title":"Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles","volume":"140","author":"Ettefagh","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/03009740902922612","article-title":"Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors","volume":"38","author":"Exarchou","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000111523","article-title":"Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab","volume":"216","author":"Fabre","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2025.04.024_bibe10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1468-3083.2010.03770.x","article-title":"Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-alpha blocker agents: report of five cases and review of the literature","volume":"25","author":"Ferran","year":"2011","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.jid.2025.04.024_bibe11","first-page":"1654","article-title":"Development of alopecia areata universalis in a patient receiving adalimumab","volume":"142","author":"Garcia","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe12","first-page":"892","article-title":"Development of alopecia areata after biological therapy with TNF-alpha blockers: description of a case and review of the literature","volume":"27","author":"Hern\u00e1ndez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jbspin.2015.08.007","article-title":"First two cases of alopecia areata during golimumab therapy","volume":"83","author":"Huynh","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jid.2025.04.024_bibe14","article-title":"Successful treatment of concomitant alopecia universalis and Crohn's disease with upadacitinib: a case report","volume":"11","author":"Johnston","year":"2023","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.jid.2025.04.024_bibe15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000174826","article-title":"Biologic agents and alopecia areata","volume":"218","author":"Katoulis","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2025.04.024_bibe16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2310\/7750.2008.07095","article-title":"Alopecia areata following adalimumab","volume":"13","author":"Kirshen","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2025.04.024_bibe17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/abd1806-4841.20142944","article-title":"Alopecia universalis during treatment with leflunomide and adalimumab - case report","volume":"89","author":"Lazzarini","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.annder.2011.01.047","article-title":"Pelade au cours d'un traitement par anti-TNF alpha : neuf cas [Alopecia areata during anti-TNF alpha therapy: nine cases]","volume":"138","author":"Le Bidre","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.04.024_bibe19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists","volume":"156","author":"Lee","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bcp.12929","article-title":"A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel\u00ae) in healthy subjects","volume":"82","author":"Lee","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jid.2025.04.024_bibe21","article-title":"Immune-mediated skin lesions related to biological disease-modifying antirheumatic drugs: a 22-year experience of a tertiary center","author":"Martins","year":"2023","journal-title":"ARP Rheumatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe22","doi-asserted-by":"crossref","DOI":"10.5070\/D3237035733","article-title":"Adalimumab-related alopecia in a patient affected by psoriasis","volume":"23","author":"Mel\u00e9-Ninot","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jid.2025.04.024_bibe23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000335264","article-title":"Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature","volume":"25","author":"Navarro","year":"2012","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.jid.2025.04.024_bibe24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/0378-6323.113097","article-title":"Alopecia areata in a patient receiving infliximab","volume":"79","author":"Ormaechea-Perez","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.jid.2025.04.024_bibe25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00393-018-0464-z","article-title":"Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab","volume":"77","author":"Ostojic","year":"2018","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/09273940802596559","article-title":"Alopecia areata during etanercept therapy","volume":"17","author":"Pan","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jid.2025.04.024_bibe27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000113945","article-title":"Alopecia areata universalis elicited during treatment with adalimumab","volume":"216","author":"Pelivani","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2025.04.024_bibe28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archderm.141.6.759","article-title":"Recurrence of alopecia areata in a patient receiving etanercept injections","volume":"141","author":"Posten","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1590\/abd1806-4841.20153084","article-title":"Alopecia secondary to anti-tumor necrosis factor-alpha therapy","volume":"90","author":"Ribeiro","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2025.04.024_bibe30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jaad.2014.03.005","article-title":"Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study","volume":"70","author":"Tauber","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.jid.2025.04.024_bibe31","doi-asserted-by":"crossref","DOI":"10.5070\/D32111029286","article-title":"Adalimumab-induced psoriatic alopecia\/alopecia areata-like reaction in a patient with Crohn's disease","volume":"21","author":"Toda-Brito","year":"2015","journal-title":"Dermatol Online J."},{"key":"10.1016\/j.jid.2025.04.024_bibe32","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archderm.142.12.1653","article-title":"Alopecia areata during treatment with biologic agents","volume":"142","author":"Tosti","year":"2006","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.jid.2025.04.024_bibe33","first-page":"596","article-title":"Alopecia universalis and onychodystrophy during treatment with adalimumab","volume":"33","author":"Youssef","year":"2020","journal-title":"Proc (Bayl Univ Med Cent)."}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:21:31Z","timestamp":1790817691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25004737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":113,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022202X25004737"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.024","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons from TNF-\u03b1 Inhibitor\u2013Induced Alopecia Areata: Does TNF-\u03b1 Operate as a Hair Follicle Immune Privilege Guardian under Inflammatory Conditions?","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Investigative Dermatology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}